Concepedia

Jon Voutila

JV

7

Publications

472

Citations

7

H-Index

2008

Active since

Affiliations

Imperial College London(Current)

City of Hope

Beckman Research Institute

National Taiwan University

University of California, Los Angeles

Jon Voutila is an author at Imperial College London specializing in medicine, liver, and gene expression.

ORCID

Top concepts

Publications per year

2008–2022

7

Publications

7

MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial

Debashis Sarker, Ruth Plummer, Tim Meyer et al. · Clinical Cancer Research · 2020 · 156 citations · Full text

Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver Cancer

Jon Voutila, Vikash Reebye, Thomas C. Roberts et al. · Molecular Therapy · 2017 · 118 citations · Full text

Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer

Vikash Reebye, Kai‐Wen Huang, Vivian Lin et al. · Oncogene · 2018 · 92 citations · Full text

, , +21

Gene Expression Profile Changes After Short-activating RNA-mediated Induction of Endogenous Pluripotency Factors in Human Mesenchymal Stem Cells

Jon Voutila, Pål Sætrom, Paul J. Mintz et al. · Molecular Therapy — Nucleic Acids · 2012 · 39 citations · Full text

Expression profile of CREB knockdown in myeloid leukemia cells

Matteo Pellegrini, Jerry C. Cheng, Jon Voutila et al. · BMC Cancer · 2008 · 33 citations · Full text

Rows per page

1–5 of 7